Table 4

Median survival as a function of pretreatment VEGF or bFGF urine level

A. Pretreatment VEGF urine level
VEGFnMedian survival (95% CI)
Low (≤28a)5217 mo (14–22)
P = 0.024
High (>28)4910 mo (6–13)
B. Pretreatment bFGF urine level
bFGF n Median survival (95% CI)
Low (≤0.5b)5216 mo (9–19)
P = 0.150
High (>0.5)4913 mo (8–16)
  • a Median, 28 pg/ml; log-rank test, 5.09 (1 degree of freedom).

  • b Median, 0.5 pg/ml; log-rank test, 2.09 (1 degree of freedom).